- Home
- FFWM vs AUTL Comparison
FFWM vs AUTL Comparison
Compare FFWM & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FFWM
- AUTL
- Stock Information
- Founded
- FFWM 1990
- AUTL 2014
- Country
- FFWM United States
- AUTL United Kingdom
- Employees
- FFWM N/A
- AUTL N/A
- Industry
- FFWM Major Banks
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FFWM Finance
- AUTL Health Care
- Exchange
- FFWM Nasdaq
- AUTL Nasdaq
- Market Cap
- FFWM 409.3M
- AUTL 590.8M
- IPO Year
- FFWM 2014
- AUTL 2018
- Fundamental
- Price
- FFWM $5.33
- AUTL $2.16
- Analyst Decision
- FFWM Buy
- AUTL Strong Buy
- Analyst Count
- FFWM 4
- AUTL 3
- Target Price
- FFWM $6.75
- AUTL $10.20
- AVG Volume (30 Days)
- FFWM 516.6K
- AUTL 1.1M
- Earning Date
- FFWM 01-30-2025
- AUTL 03-13-2025
- Dividend Yield
- FFWM 0.20%
- AUTL N/A
- EPS Growth
- FFWM N/A
- AUTL N/A
- EPS
- FFWM N/A
- AUTL N/A
- Revenue
- FFWM $96,072,000.00
- AUTL $10,091,000.00
- Revenue This Year
- FFWM N/A
- AUTL $851.83
- Revenue Next Year
- FFWM $12.65
- AUTL $224.65
- P/E Ratio
- FFWM N/A
- AUTL N/A
- Revenue Growth
- FFWM N/A
- AUTL 82.71
- 52 Week Low
- FFWM $4.66
- AUTL $2.07
- 52 Week High
- FFWM $8.72
- AUTL $7.37
- Technical
- Relative Strength Index (RSI)
- FFWM 33.41
- AUTL 41.40
- Support Level
- FFWM $4.66
- AUTL $2.07
- Resistance Level
- FFWM $6.46
- AUTL $2.26
- Average True Range (ATR)
- FFWM 0.29
- AUTL 0.12
- MACD
- FFWM -0.08
- AUTL 0.01
- Stochastic Oscillator
- FFWM 30.39
- AUTL 25.00
About FFWM First Foundation Inc.
First Foundation Inc is a financial services company. It is engaged in providing investment management and financial planning services for high-net-worth individuals, retirement plans, charitable institutions, and private foundations. The company focuses on segments namely Banking and Wealth Management. It also offers loans to individuals and entities that own and operate multifamily residential and commercial real estate properties as well as business banking products and services to small to moderate-sized businesses, professional firms, and consumer banking products and services to individuals.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.